J7309 HCPCS Level II code: Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram
CMS terminated J7309: its last date of service was Dec 31, 2025. It stays here for looking up older claims; newer services need a current code.
Official description
J7309Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram
Short description: Methyl aminolevulinate, top
HCPCS · United States
Notes for J7309
As CMS prints them, with any note J7309 takes from the headings above it.
Note
- CMS processing note 0165: PUB 100.3 250.4 (IOM).
Medicare details
The indicators CMS publishes with J7309 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Other medical items or services
- BETOS category
- Other drugs
- Added
- Jan 1, 2011
- Terminated after
- Dec 31, 2025
Where J7309 sits
- 1J codesDrugs administered other than orally
- 2Terminated J7309Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code J7309 still valid?
No. CMS terminated J7309; its last date of service was Dec 31, 2025. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover J7309?
CMS lists J7309’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J7309
All J codesJ7302Levonorgestrel-releasing intrauterine contraceptive system, 52 mgJ7303Contraceptive supply, hormone containing vaginal ring, eachJ7304Contraceptive supply, hormone containing patch, eachJ7306Levonorgestrel (contraceptive) implant system, including implants and suppliesJ7307Etonogestrel (contraceptive) implant system, including implant and suppliesJ7308Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)J7310Ganciclovir, 4.5 mg, long-acting implantJ7311Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mgJ7312Injection, dexamethasone, intravitreal implant, 0.1 mgJ7313Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mgJ7314Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mgJ7315Mitomycin, ophthalmic, 0.2 mg